返回 Agenda
Mergers & Acquisitions – The Multinational Pharma Quagmire
Session Chair(s)
Moin Don
Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),
International Society of Pharmacovigilance (ISoP), India
Mergers & Acquisitions (M&A) within pharma companies has become a regular phenomenon and needs deeper analysis to understand its dynamics. During M&A, it is not only the PV domain which needs critical attention from a management perspective but equally important are others functions such as Legal/Regulatory Affairs/ Safety Database/ Change in QPPV &PSMF, etc. This session shall explore encompassing all such challenges faced by pharma companies during M&A process.
Speaker(s)
Contributing Panelist
Seema Jaitly, DrMed
United Kingdom
Managing Director
Contributing Panelist
Amit Patil, PharmD
Pfizer Limited, India
Sr. Manager, Regulatory Affairs
Contributing Panelist
Preeti Verma
Qinecsa Solutions , United States
Senior Director, Solution Architect Leader, Business Development,
Contributing Panelist
Gaurav Shah
Viatris Laboratories Ltd, India
Deputy General Manager, Product Safety and Risk Management
Contributing Panelist
Gaurang Shah
GAURANG SHAH & ASSOCIATES, India
Proprietor